'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seniors' - WSJ Exclusive

Bill Ackman Backs Mark Cuban's Drug Pricing Model: These Healthcare Stocks Could Win—Or Lose

Bill Ackman backed Mark Cuban's drug pricing model. Here's which healthcare stocks could benefit—and which face pressure.

FDA Says It Has Received 990 Adverse Event Reports Tied To Compounded Semaglutide And More Than 730 Tied To Compounded Tirzepatide; Establishes Import Alert For Compounded GLP-1 Active Pharmaceutical Ingredients

Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today

The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.

Here's Why Investors Should Stay Neutral on TDOC Stock for Now

Teladoc Health (TDOC) is positioned for growth through chronic care expansion, international presence, and its upcoming Teladoc One platform, with the stock trading at a valuation discount. However, the company faces headwinds from declining BetterHelp revenues, intense virtual care competition, and persistent unprofitability with a $16.5 billion accumulated deficit.

UBS Maintains Buy on CVS Health, Lowers Price Target to $118

eHealth (EHTH) Stock Climbs Over 8% After Hours: Here's Why

eHealth shares soared over 8% in after-hours trading Thursday after executives received RSU grants and a director sold shares.